Risks, regulation, and rewards in new drug development in the United States
Regul Toxicol Pharmacol
.
1994 Apr;19(2):228-35.
doi: 10.1006/rtph.1994.1021.
Author
J A DiMasi
1
Affiliation
1
Center for the Study of Drug Development, Tufts University, Boston, Massachusetts 02111.
PMID:
8041920
DOI:
10.1006/rtph.1994.1021
No abstract available
Publication types
Comparative Study
Review
MeSH terms
Chemistry, Pharmaceutical / economics*
Chemistry, Pharmaceutical / legislation & jurisprudence*
Drug Approval
Health Care Reform
Legislation, Drug
Marketing of Health Services
Risk Factors
United States